Infection Control Surveillance Solutions Market Size, Share, and Trends 2024 to 2033

Infection Control Surveillance Solutions Market (By Component: Software, Services; By End-User: Hospitals, Clinics, Specialty Surgical Centers, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : May 2024
  • Report Code : 4345
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Infection Control Surveillance Solutions Market 

5.1. COVID-19 Landscape: Infection Control Surveillance Solutions Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Infection Control Surveillance Solutions Market, By Component

8.1. Infection Control Surveillance Solutions Market, by Component, 2024-2033

8.1.1. Software

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Services

8.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Infection Control Surveillance Solutions Market, By End-User

9.1. Infection Control Surveillance Solutions Market, by End-User, 2024-2033

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Clinics

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Specialty Surgical Centers

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Ambulatory Surgical Centers

9.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Infection Control Surveillance Solutions Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Component (2021-2033)

10.1.2. Market Revenue and Forecast, by End-User (2021-2033)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Component (2021-2033)

10.1.3.2. Market Revenue and Forecast, by End-User (2021-2033)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Component (2021-2033)

10.1.4.2. Market Revenue and Forecast, by End-User (2021-2033)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Component (2021-2033)

10.2.2. Market Revenue and Forecast, by End-User (2021-2033)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Component (2021-2033)

10.2.3.2. Market Revenue and Forecast, by End-User (2021-2033)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Component (2021-2033)

10.2.4.2. Market Revenue and Forecast, by End-User (2021-2033)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Component (2021-2033)

10.2.5.2. Market Revenue and Forecast, by End-User (2021-2033)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Component (2021-2033)

10.2.6.2. Market Revenue and Forecast, by End-User (2021-2033)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Component (2021-2033)

10.3.2. Market Revenue and Forecast, by End-User (2021-2033)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Component (2021-2033)

10.3.3.2. Market Revenue and Forecast, by End-User (2021-2033)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Component (2021-2033)

10.3.4.2. Market Revenue and Forecast, by End-User (2021-2033)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Component (2021-2033)

10.3.5.2. Market Revenue and Forecast, by End-User (2021-2033)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Component (2021-2033)

10.3.6.2. Market Revenue and Forecast, by End-User (2021-2033)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Component (2021-2033)

10.4.2. Market Revenue and Forecast, by End-User (2021-2033)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Component (2021-2033)

10.4.3.2. Market Revenue and Forecast, by End-User (2021-2033)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Component (2021-2033)

10.4.4.2. Market Revenue and Forecast, by End-User (2021-2033)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Component (2021-2033)

10.4.5.2. Market Revenue and Forecast, by End-User (2021-2033)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Component (2021-2033)

10.4.6.2. Market Revenue and Forecast, by End-User (2021-2033)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Component (2021-2033)

10.5.2. Market Revenue and Forecast, by End-User (2021-2033)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Component (2021-2033)

10.5.3.2. Market Revenue and Forecast, by End-User (2021-2033)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Component (2021-2033)

10.5.4.2. Market Revenue and Forecast, by End-User (2021-2033)

Chapter 11. Company Profiles

11.1. Becton

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Dickinson and Company

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Premier Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Wolters Kluwer N.V

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Gojo Industries

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. RL Solutions

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Baxter International Inc

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Premier Inc.

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Truven Health Analytics (An IBM Company)

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global infection control surveillance solutions market size is expected to increase USD 2,614.56 million by 2033 from USD 766.82 million in 2023.

The global infection control surveillance solutions market will register growth rate of 13.05% between 2024 and 2033.

The major players operating in the infection control surveillance solutions market are Becton, Dickinson and Company, Premier Inc., Wolters Kluwer N.V, Gojo Industries, RL Solutions, Baxter International Inc., Premier Inc., Truven Health Analytics (An IBM Company), and Others.

The driving factors of the infection control surveillance solutions market are the increasing advancements for hospital safety and rising investments in research and development activities.

North America region will lead the global infection control surveillance solutions market during the forecast period 2024 to 2033.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client